INOVIO to Participate in Upcoming Scientific Conferences

, /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer and infectious diseases, today announced that it will participate in the following scientific conferences: American Society of Gene and Cell Therapy Annual Meeting (Boston) Poster Presentation: Bleeding phenotype correction in hemophilia A mice following in vivo Factor VIII gene transfer by electroporation in skeletal muscle cells Date: Tuesday, May 12 Time: 5 - 6:30 PM ET American Society of Clinical Oncology Annual Meeting (Chicago) Poster Presentation: B cell responses in Recurrent Respiratory Papillomatosis patients treated with DNA immunotherapy INO-3107 Date: Saturday, May 30 Time: 1:30 - 4:30 PM CDT Available abstracts will be shared on INOVIO's website following presentations. About INOVIO INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com. Contacts Media: Jennie Willson, (267) 429-8567, [email protected] Investors: Peter Vozzo, ICR Healthcare, (443) 213-0505, [email protected] View original content to download multimedia:https://www.prnewswire.com/news-releases/inovio-to-participate-in-upcoming-scientific-conferences-302766450.html SOURCE INOVIO Pharmaceuticals, Inc.